TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34973284

Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PTC923 20 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sapropterin 20 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: PTC923 60 mg/kg vs. Sapropterin
Number of subjects: 24

Group type: COMPARATOR
Intervention: PTC923 20 mg/kg vs. Sapropterin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg in classical PKU subjects
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg cofactor responder analysis
Number of subjects: 24
Study: 33383229

Group type: EXPERIMENTAL
Intervention: High-Touch care management strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-Tech care management strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Care management strategy
Number of subjects: 0
Study: 32421814

Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Time in Bed Regularization (TBR)
Number of subjects: 56
Study: 33585918

Group type: EXPERIMENTAL
Intervention: Structured Physical Activity (PA) program
Number of subjects: 1633

Group type: COMPARATOR
Intervention: Health Education (HE) program
Number of subjects: 1633

Group type: EXPERIMENTAL
Intervention: Ratings of perceived exertion (RPE)
Number of subjects: 1633
Study: 33081850

Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 726

Group type: COMPARATOR
Intervention: Medical treatment (control group)
Number of subjects: 726
Study: 32933850

Group type: EXPERIMENTAL
Intervention: GnRH agonist trigger
Number of subjects: 53
Study: 35148946

Group type: EXPERIMENTAL
Intervention: Endovascular revascularisation (ER)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Supervised exercise therapy (SET)
Number of subjects: 240
Study: 33878195

Group type: EXPERIMENTAL
Intervention: Low light levels (sudden reduction to mesopic, adapted mesopic, adapted mesopic with LED)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Sudden mesopic condition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adapted mesopic condition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adapted mesopic with LED lighting system
Number of subjects: 28

Group type: COMPARATOR
Intervention: AMD group
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 33290857

Group type: EXPERIMENTAL
Intervention: Parenteral oxycodone
Number of subjects: 164

Group type: COMPARATOR
Intervention: Parenteral morphine
Number of subjects: 164

Group type: COMPARATOR
Intervention: Comparison between oxycodone and morphine
Number of subjects: 164

Group type: COMPARATOR
Intervention: Adverse events
Number of subjects: 164
Study: 36070636

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIRT) for 6 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIRT)
Number of subjects: 51
Study: 33413316

Group type: EXPERIMENTAL
Intervention: F18-choline PET/CT
Number of subjects: 58

Group type: COMPARATOR
Intervention: Tc99m-sestaMIBI SPECT/CT
Number of subjects: 58
Study: 35413476

Group type: EXPERIMENTAL
Intervention: 2 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140

Group type: COMPARATOR
Intervention: 4 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140

Group type: COMPARATOR
Intervention: 6 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140
Study: 33485369

Group type: EXPERIMENTAL
Intervention: rVSV?G‐ZEBOV‐GP vaccine (with and without booster dose at 56 days)
Number of subjects: 4789

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV,MVA‐FN‐Filo vaccine regimen (Ad26.ZEBOV first dose, MVA‐FN‐Filo 56 days later)
Number of subjects: 4789

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4789
Study: 34580784

Group type: EXPERIMENTAL
Intervention: Exercise intervention for 6 months
Number of subjects: 2051
Study: 32374768

Group type: EXPERIMENTAL
Intervention: Probe-based confocal endomicroscopy with automatic segmentation algorithm
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (healthy lung areas)
Number of subjects: 46
Study: 34999321

Group type: EXPERIMENTAL
Intervention: Daily iron intake below average requirement of 5 mg/day in infants
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Higher daily iron intake per body weight (mg/kg)
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Frequent consumption of milk products in toddlers
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Consumption of meat and fish
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Duration of gestation and growth
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Growth in boys
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Faster growth in girls
Number of subjects: 766
Study: 34702425

Group type: EXPERIMENTAL
Intervention: Digital game
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Storybook
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Storybook and reward (stickers)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Portuguese Food Wheel Guide
Number of subjects: 162
Study: 32450737

Group type: EXPERIMENTAL
Intervention: Simulation training using an M&T simulator
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no simulation training)
Number of subjects: 63
Study: 35353086

Group type: EXPERIMENTAL
Intervention: Definitive abutment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Multiple disconnections and reconnections of the abutment (control group)
Number of subjects: 13
Study: 32489080

Group type: EXPERIMENTAL
Intervention: Kuntai Capsules combined with GnRH-a
Number of subjects: 1041

Group type: COMPARATOR
Intervention: GnRH-a alone
Number of subjects: 1041
Study: 35754106

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 33355658

Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal lavage
Number of subjects: 199

Group type: COMPARATOR
Intervention: Colon resection
Number of subjects: 199
Study: 35748777

Group type: EXPERIMENTAL
Intervention: LEM 10 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LEM 20 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LEM 30 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: ZOL 30 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SUV 40 mg
Number of subjects: 32
Study: 32079487

Group type: EXPERIMENTAL
Intervention: Radioiodine treatment (131I)
Number of subjects: 56
Study: 36479556

Group type: EXPERIMENTAL
Intervention: Mindfulness-based habit reversal training (MHRT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Psychoeducation and supportive therapy (PST)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Neural correlates of MHRT
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Neural correlates of HRT and PST
Number of subjects: 160
Study: 33298062

Group type: EXPERIMENTAL
Intervention: BDP/F/G
Number of subjects: 23

Group type: COMPARATOR
Intervention: BDP/F
Number of subjects: 23
Study: 35641000

Group type: EXPERIMENTAL
Intervention: Electronically-assisted inspiratory muscle training (EIMT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Spontaneous breathing with T-piece
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Manual EIMT
Number of subjects: 104
Study: 33053005

Group type: EXPERIMENTAL
Intervention: Massage followed by rest (G1)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Massage followed by Reiki (G2)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control (G3)
Number of subjects: 101
Study: 35182194

Group type: EXPERIMENTAL
Intervention: Cluster dextrin (CDX)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose (GLC)
Number of subjects: 10
Study: 32933794

Group type: EXPERIMENTAL
Intervention: Individualized audiovisual education
Number of subjects: 124
Study: 34600777

Group type: EXPERIMENTAL
Intervention: Moderation messages with low-risk behaviors
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Moderation messages with high-risk behaviors
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Abstinence messages with low-risk behaviors
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Abstinence messages with high-risk behaviors
Number of subjects: 476

Group type: COMPARATOR
Intervention: Generic guidelines after full range of risk behaviors infographic
Number of subjects: 476

Group type: COMPARATOR
Intervention: Generic guidelines after no risk behaviors infographic
Number of subjects: 476
Study: 33819214

Group type: EXPERIMENTAL
Intervention: Low-dose continuous ultrasound (3 sessions per week for 7 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Far-infrared treatment (3 sessions per week for 7 weeks)
Number of subjects: 30
Study: 32785709

Group type: EXPERIMENTAL
Intervention: Rifampin (10 mg/kg/d)
Number of subjects: 6859

Group type: COMPARATOR
Intervention: Isoniazid (5 mg/kg/d)
Number of subjects: 6859

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 6859

Group type: COMPARATOR
Intervention: Isoniazid
Number of subjects: 6859

Group type: EXPERIMENTAL
Intervention: Rifampin among participants living with HIV
Number of subjects: 6859
Study: 35138360

Group type: EXPERIMENTAL
Intervention: Preoperative factors identified as statistically significant predictors of 10-year mortality
Number of subjects: 3102

Group type: COMPARATOR
Intervention: Univariable models for mortality
Number of subjects: 3102
Study: 34039209

Group type: EXPERIMENTAL
Intervention: Inpatient satisfaction scores
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Follow-up satisfaction scores (4 to 6 weeks after discharge)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Concordance between inpatient and follow-up satisfaction scores
Number of subjects: 231
Study: 36172719

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative medicine (OMM) - 2 treatments
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative medicine (OMM) - 1 treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Concussion-education - 2 sessions
Number of subjects: 25
Study: 34406400

Group type: EXPERIMENTAL
Intervention: Mammography with ultrasonography
Number of subjects: 19213

Group type: COMPARATOR
Intervention: Mammography alone
Number of subjects: 19213
Study: 32710204

Group type: EXPERIMENTAL
Intervention: Hyperthermic IPEC of cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normothermic IPEC of cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2) with IPEC duration of 1-2 hours
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cisplatin (100 and 120 mg/m2) with IPEC duration of 1 hour
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50
Study: 33668075

Group type: EXPERIMENTAL
Intervention: Breath-hold (BH) scan and cine CT imaging sessions
Number of subjects: 14
Study: 33053991

Group type: EXPERIMENTAL
Intervention: Adolescent gastric cancer patients
Number of subjects: 63
Study: 34518254

Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg for a minimum of 12 weeks before surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for a minimum of 12 weeks before surgery
Number of subjects: 0
Study: 32719760

Group type: EXPERIMENTAL
Intervention: 120-min ECI sessions
Number of subjects: 20

Group type: COMPARATOR
Intervention: 90-min ECI sessions
Number of subjects: 20
Study: 35553981

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) with Levels software
Number of subjects: 25

Group type: COMPARATOR
Intervention: Classic glucometer (Control)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Both CGM and Control groups
Number of subjects: 25
Study: 33751727

Group type: EXPERIMENTAL
Intervention: Medications (bronchodilators and inhaled corticosteroids)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preventive strategies and treatments that alter the course of disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Understanding gender-based predictors of efficacy of therapeutic interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exploration of disease trajectories of other non-communicable diseases (NCD)
Number of subjects: 0
Study: 33257417

Group type: EXPERIMENTAL
Intervention: Planning prompt (calendar showing dates and prompting to select a date and time)
Number of subjects: 2362

Group type: COMPARATOR
Intervention: Control (calendar showing dates of community health campaign)
Number of subjects: 2362

Group type: EXPERIMENTAL
Intervention: Planning prompt among men enrolled ≤40 days before campaigns
Number of subjects: 2362

Group type: EXPERIMENTAL
Intervention: Planning prompt among men enrolled >40 days before campaigns
Number of subjects: 2362
Study: 35459607

Group type: EXPERIMENTAL
Intervention: Structured T2DM group education programme
Number of subjects: 367

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 367
Study: 34808726

Group type: EXPERIMENTAL
Intervention: onaBotulinum Toxin type A injection (100 units)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 31
Study: 32804527

Group type: EXPERIMENTAL
Intervention: LGB discrimination
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: LGB affirmation
Number of subjects: 310

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 310
Study: 35903663

Group type: EXPERIMENTAL
Intervention: Selective use of lumbar drains (LD) during perioperative period
Number of subjects: 153
Study: 34462241

Group type: EXPERIMENTAL
Intervention: Extreme learning machine network with particle swarm optimization
Number of subjects: 10060

Group type: COMPARATOR
Intervention: Support vector machine
Number of subjects: 10060

Group type: COMPARATOR
Intervention: Bayesian networks
Number of subjects: 10060

Group type: COMPARATOR
Intervention: Various models for all syndromes
Number of subjects: 10060
Study: 35965162

Group type: COMPARATOR
Intervention: Intravenous Acetaminophen (1,000 mg)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Intravenous Hydromorphone (0.5 mg)
Number of subjects: 162
Study: 32808693

Group type: EXPERIMENTAL
Intervention: Randomly selected sites
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sites selected with site-selection bias
Number of subjects: 0
Study: 36002801

Group type: EXPERIMENTAL
Intervention: Qualitative interviews with retention staff
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Qualitative interviews with recruitment staff
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Theoretical Domains Framework (TDF) analysis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Thematic analysis of belief statements
Number of subjects: 25
Study: 33883291

Group type: EXPERIMENTAL
Intervention: Multicomponent supervised and unsupervised training program focusing on muscle power (5 weeks supervised, 6 weeks unsupervised)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (robust)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Multicomponent supervised and unsupervised training program focusing on muscle power
Number of subjects: 35
Study: 36479062

Group type: EXPERIMENTAL
Intervention: AmeriCorps Seniors volunteering program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Active control (self-guided life review)
Number of subjects: 300
Study: 33448933

Group type: EXPERIMENTAL
Intervention: VRelax
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard relaxation
Number of subjects: 50
Study: 36109816

Group type: EXPERIMENTAL
Intervention: Mask promotion intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unblinded and supposedly blinded steps
Number of subjects: 0
Study: 34932440

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 635

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 635
Study: 36931429

Group type: EXPERIMENTAL
Intervention: Cataract surgery with endoscopic cyclophotocoagulation (ECP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Cataract surgery alone
Number of subjects: 160
Study: 32643311

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.12)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.145)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.17)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FIO2 0.2093)
Number of subjects: 12
Study: 33044990

Group type: EXPERIMENTAL
Intervention: Tobacco Cessation on Prescription (TCP)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Individualized counseling from a tobacco cessation specialist
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Empathetic approach in treatment and long-term follow-up
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Holistic approach combined with interventions outside the health care system
Number of subjects: 8
Study: 35198926

Group type: EXPERIMENTAL
Intervention: Acupuncture plus moxibustion (3 sessions per week for 12 weeks)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Acupuncture plus moxibustion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 66
Study: 32589775

Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) 75 mg or 150 mg lyophilized formulation infused over 30 minutes or 2 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) 150 mg once daily for 7 or 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) single-dose i.v. administration over 2 hours (dose range 3-225 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remdesivir (RDV) solution and lyophilized formulations
Number of subjects: 0
Study: 33809922

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 60
Study: 32028398

Group type: EXPERIMENTAL
Intervention: Tecfidera (dimethyl fumarate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35458231

Group type: EXPERIMENTAL
Intervention: High fiber rye foods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Refined wheat foods
Number of subjects: 0
Study: 34111765

Group type: EXPERIMENTAL
Intervention: OUES2min
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: OUES3min
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: OUES4min
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: CPET-measured VO2peak
Number of subjects: 21
Study: 32245717

Group type: EXPERIMENTAL
Intervention: Educational video about the role and responsibilities of medical students, residents, and attending surgeons.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no educational video).
Number of subjects: 140
Study: 34126510

Group type: EXPERIMENTAL
Intervention: Resin-based ion-leaching materials (RB-ILMs)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cements (RMGICs)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-viscosity glass-ionomer cements (HVGICs)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Biaxial flexural strength (B-FS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Porosity analysis using ImageJ software
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flexural modulus (4 PB-E) and flexural toughness (4 PB-T)
Number of subjects: 15
Study: 32078256

Group type: EXPERIMENTAL
Intervention: 7-day regimen (35-50 IU/kg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 10-day regimen (50-75 IU/kg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 14-day regimen (50-75 IU/kg)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 21-day regimen (100 IU/kg)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 14-day regimen
Number of subjects: 59

Group type: COMPARATOR
Intervention: 21-day regimen
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: rIX-FP infusions
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: rIX-FP
Number of subjects: 59
Study: 35431237

Group type: EXPERIMENTAL
Intervention: Glargine allocation
Number of subjects: 8365

Group type: COMPARATOR
Intervention: Clinical risk factors
Number of subjects: 8365
Study: 33712532

Group type: EXPERIMENTAL
Intervention: 18F-florbetaben visual rating protocol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 18F-florbetapir visual rating protocol
Number of subjects: 7

Group type: COMPARATOR
Intervention: All 3 approved visual rating protocols
Number of subjects: 7
Study: 32322023

Group type: EXPERIMENTAL
Intervention: 30:2 compression-to-ventilation ratio
Number of subjects: 26

Group type: COMPARATOR
Intervention: 15:2 compression-to-ventilation ratio
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both 30:2 and 15:2 ratios
Number of subjects: 26
Study: 36068186

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound guided cannulation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Blind cannulation method
Number of subjects: 40
Study: 32567290

Group type: EXPERIMENTAL
Intervention: Combination of vitamin A and D supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vitamin A only
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vitamin D only
Number of subjects: 120
Study: 36064177

Group type: EXPERIMENTAL
Intervention: Mindfulness training through a mobile application (En Calma en el Quirófano)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 82
Study: 33518325

Group type: EXPERIMENTAL
Intervention: PFA-C 250 ppm
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: PFA-C 400 ppm
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control
Number of subjects: 600
Study: 32475359

Group type: EXPERIMENTAL
Intervention: Fragmented + Coffee (300 mg caffeine)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fragmented (waking hourly for 5 min)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (habitual night of sleep)
Number of subjects: 29
Study: 34878707

Group type: EXPERIMENTAL
Intervention: Sugammadex 2 mg/kg
Number of subjects: 288

Group type: COMPARATOR
Intervention: Neostigmine 50 µg/kg
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Sugammadex 4 mg/kg
Number of subjects: 288
Study: 34389022

Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 174

Group type: COMPARATOR
Intervention: Predetermined music (MUSIC CARE® application)
Number of subjects: 174